Featured Research

from universities, journals, and other organizations

Risk of kidney disease doubled with use of fluoroquinolone antibiotics

Date:
June 3, 2013
Source:
Canadian Medical Association Journal
Summary:
The risk of acute kidney disease is doubled for people taking oral fluoroquinolone antibiotics, according to a new study.

The risk of acute kidney disease is doubled for people taking oral fluoroquinolone antibiotics, according to a study of published in CMAJ (Canadian Medical Association Journal).

Fluoroquinolones, including ciprofloxacin, levofloxacin and moxifloxacin, are common broad-spectrum antibiotics most often used to treat respiratory and urogenital infections. Case reports have indicated acute kidney injury with use, and prescription labels carry a warning of kidney failure. However, when oral fluoroquinolones are prescribed in clinical practice, kidney injury is usually not considered.

Researchers from the US and Canada undertook a study to determine the risk of acute kidney injury with the use of oral fluoroquinolones for adult men 40󈟁 years old enrolled in the US LifeLink Health Plan Claims Database between 2001 and 2011. There were 1292 cases of acute kidney disease and 12 651 controls in the study. Researchers excluded people who had a history of chronic kidney disease or dialysis because they can increase the risk of acute injury. They found that current use of oral fluoroquinolones increased the risk of acute kidney injury; the risk was highest with ciprofloxacin, followed by moxifloxacin. Past use did not increase the risk nor did the use of amoxicillin or azithromycin. They also found that concurrent use of an oral fluoroquinolone and a renin-angiotensin-system blocker, a popular class of cardiovascular medication, increases the risk of acute renal failure by 4.5 fold.

"We found a twofold increased risk of acute kidney injury requiring hospital admission with the use of fluoroquinolone antibiotics among adult men, using 2 analytic techniques," writes Dr. Mahyar Etminan, of the Child & Family Research Institute, Department of Pediatrics, University of British Columbia, and the Provincial Health Services Authority, with coauthors.

"The twofold differential in risk in current users suggests that acute kidney injury secondary to fluoroquinolone use is an acute adverse event."

The authors suggest that physicians need to be aware of the risks of kidney injury when prescribing these drugs. "Although it is clear that the risk of death due to serious infections outweighs the risks associated with the use of fluoroquinolones, the potential for acute kidney injury raises the importance of vigilant prescribing," they conclude.


Story Source:

The above story is based on materials provided by Canadian Medical Association Journal. Note: Materials may be edited for content and length.


Journal Reference:

  1. S. T. Bird, M. Etminan, J. M. Brophy, A. G. Hartzema, J. A. C. Delaney. Risk of acute kidney injury associated with the use of fluoroquinolones. Canadian Medical Association Journal, 2013; DOI: 10.1503/cmaj.121730

Cite This Page:

Canadian Medical Association Journal. "Risk of kidney disease doubled with use of fluoroquinolone antibiotics." ScienceDaily. ScienceDaily, 3 June 2013. <www.sciencedaily.com/releases/2013/06/130603135311.htm>.
Canadian Medical Association Journal. (2013, June 3). Risk of kidney disease doubled with use of fluoroquinolone antibiotics. ScienceDaily. Retrieved July 24, 2014 from www.sciencedaily.com/releases/2013/06/130603135311.htm
Canadian Medical Association Journal. "Risk of kidney disease doubled with use of fluoroquinolone antibiotics." ScienceDaily. www.sciencedaily.com/releases/2013/06/130603135311.htm (accessed July 24, 2014).

Share This




More Health & Medicine News

Thursday, July 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
China's Ageing Millions Look Forward to Bleak Future

China's Ageing Millions Look Forward to Bleak Future

AFP (July 24, 2014) China's elderly population is expanding so quickly that children struggle to look after them, pushing them to do something unexpected in Chinese society- move their parents into a nursing home. Duration: 02:07 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins